Cart

YOUR CART IS EMPTY

Add research compounds to begin your order.

Exact TB-500 identity and direct-fragment evidenceSee approved evidence mapCompleted

Journal of Chromatography B

TB5-STUDY-P004

Rahaman MM, et al. Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro. Journal of Chromatography B. 2024. DOI: 10

Study design

Record details

Design: Exact TB-500 identity and direct-fragment evidence

Evidence record

Endpoints, findings, and limitations

Limitations

This study record is an evidence-index entry. Interpret the design, material, population or model, endpoints, findings, and limitations only within the linked approved source and compound evidence map; do not transfer outcomes across compounds, materials, cohorts, or models.

Reports and sources

Reference ledger

P004Exact TB-500 identity and direct-fragment evidence

Journal of Chromatography B

Rahaman MM, et al. Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro. Rahaman MM, et al. Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro. Journal of Chromatography B. 2024. DOI: 10.1016/j.jchromb.2024.124033. PMID: 38382158. https://pubmed.ncbi.nlm.nih.gov/38382158/(2024). DOI: 10.1016/j.jchromb.2024.124033